Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE I. Weekly cases of selected* infrequently reported notifiable diseases (<1,000 cases reported during the preceding year), excluding U.S. Territories -- United States, week ending January 9, 2016 (WEEK 01) †
Disease Total cases reported for previous years
Current
week
Cum
2016
5-year
weekly
average§
2015 2014 2013 2012 2011 States reporting cases
during current week (Count)
Anthrax - - - - - - - 1  
Arboviral diseases ¶,**:                  
Chikungunya virus †† NN NN NN NN NN NN NN NN  
Eastern equine encephalitis virus - - 0 5 8 8 15 4  
Jamestown Canyon virus §§ - - - 7 11 22 2 3  
La Crosse virus §§ - - - 48 80 85 78 130  
Powassan virus - - - 6 8 12 7 16  
St. Louis encephalitis virus - - 0 19 10 1 3 6  
Western equine encephalitis virus - - - - - - - -  
Botulism, total - - 3 178 161 152 168 153  
foodborne - - 0 40 15 4 27 24  
infant - - 2 119 127 136 123 97  
other(wound & unspecified) - - 0 19 19 12 18 32  
Brucellosis - - 2 118 92 99 114 79  
Chancroid - - 0 17 - - 15 8  
Cholera - - 1 1 5 14 17 40  
Cyclosporiasis ** 1 1 2 609 388 784 123 151 NYC (1 )
Diphtheria - - 0 - 1 - 1 -  
Haemophilus influenzae,
invasive disease (age <5 yrs) ¶¶:
                 
serotype b - - 1 23 40 31 30 14  
not typable serotype - - 5 122 128 141 115 93  
other serotype - - - 267 266 233 263 230  
unknown serotype 3 3 4 52 39 34 37 48 OH (2 ), GA (1 )
Hansen's disease ** 1 1 2 64 88 81 82 82 FL (1 )
Hantavirus Infections **:                  
Hantavirus infection (non-HPS) †† NN NN NN NN NN NN NN NN  
Hantavirus pulmonary syndrome (HPS) - - 0 12 32 21 30 23  
Hemolytic uremic syndrome, post-diarrheal ** 2 2 3 232 250 329 274 290 NYC (1 ), SC (1 )
Hepatitis B, virus infection perinatal - - 1 27 47 48 40 NP  
Influenza-associated pediatric mortality **, *** 1 1 4 130 141 160 52 118 PR (1 )
Leptospirosis ** - - 0 28 38 NN NN NN  
Listeriosis 2 2 12 690 769 735 727 870 PA (1 ), FL (1 )
Measles ††† - - 5 189 667 187 55 220  
Meningococcal disease, invasive §§§:                  
serogroup ACWY - - 4 84 123 142 161 257  
serogroup B - - 2 82 89 99 110 159  
other serogroup - - 1 18 25 17 20 20  
unknown serogroup 1 1 6 168 196 298 260 323 CA (1 )
Novel influenza A virus infections ¶¶¶ 1 1 4 6 3 21 313 14 NJ (1 )
Plague - - - 9 10 4 4 3  
Poliomyelitis, paralytic - - - - - 1 - -  
Polio virus infection, nonparalytic ** - - - - - - - -  
Psittacosis ** - - 0 7 8 6 2 2  
Q fever total **: - - 3 143 168 170 135 134  
acute - - 2 123 132 137 113 110  
chronic - - 0 20 36 33 22 24  
Rabies, human - - 0 1 1 2 1 6  
SARS CoV - - - - - - - -  
Smallpox - - - - - - - -  
Streptococcal toxic shock syndrome ** 1 1 5 250 259 224 194 168 SC (1 )
Syphilis, congenital **** - - 7 346 458 348 322 360  
Toxic shock syndrome (staphylococcal) ** 1 1 1 99 59 71 65 78 MO (1 )
Trichinellosis ** - - 0 7 14 22 18 15  
Tularemia - - 1 247 180 203 149 166  
Typhoid fever 3 3 6 322 349 338 354 390 NYC (2 ), FL (1 )
Vancomycin-intermediate Staphylococcus aureus ** - - 3 153 212 248 134 82  
Vancomycin-resistant Staphylococcus aureus ** - - - 1 - - 2 -  
Viral hemorrhagic Fevers ††††:                  
Crimean-Congo hemorrhagic fever - - - - NP NP NP NP  
Ebola hemorrhagic fever - - - - 4 NP NP NP  
Guanarito hemorrhagic fever - - - - NP NP NP NP  
Junin hemorrhagic fever - - - - NP NP NP NP  
Lassa fever - - - - 1 NP NP NP  
Lujo virus - - - - NP NP NP NP  
Machupo hemorrhagic fever - - - - NP NP NP NP  
Marburg fever - - - - NP NP NP NP  
Sabia-associated hemorrhagic fever - - - - NP NP NP NP  
Yellow fever - - - - - - - -  
  • -: No reported cases N: Not reportable. NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2015 and 2016 are provisional and subject to change. Data for years 2011 through 2014 are finalized. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.
  • † This table does not include cases from the U.S. territories. Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions.
  • § Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. Additional information is available at http://wwwn.cdc.gov/nndss/document/5yearweeklyaverage.pdf.
  • ¶ Includes both neuroinvasive and nonneuroinvasive. Updated weekly reports from the Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II.
  • ** Not reportable in all reporting jurisdictions. Data from states where the condition is not reportable are excluded from this table, except for the arboviral diseases and influenza-associated pediatric mortality. Reporting exceptions are available at http://wwwn.cdc.gov/nndss/downloads.html.
  • †† Data for Chikungunya virus and Hantavirus infection, non-Hantavirus Pulmonary Syndrome (HPS), will be displayed in this table after the CDC obtains Office of Management and Budget (OMB) Paperwork Reduction Act (PRA) approval to receive data for these conditions.
  • §§ Jamestown Canyon virus and Lacrosse virus have replaced California serogroup diseases.
  • ¶¶ Data for Haemophilus influenzae (all ages, all serotypes) are available in Table II.
  • *** Please refer to the MMWR publication for weekly updates to the footnote for this condition.
  • ††† Please refer to the MMWR publication for weekly updates to the footnote for this condition.
  • §§§ Data for meningococcal disease (all serogroups) are available in Table II.
  • ¶¶¶ Please refer to the MMWR publication for weekly updates to the footnote for this condition.
  • **** Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
  • †††† Please refer to the MMWR publication for weekly updates to the footnote for this condition.